Endocrinology

Top Story

Biologics application submitted for osteoporosis drug

July 23, 2016

A Biologics License Application for romosozumab, an investigational monoclonal antibody much anticipated as a therapy for the treatment of osteoporosis in postmenopausal women at high risk for fracture, has been submitted to the FDA by co-developers Amgen and UCB, according to a press release from Amgen.

Romosozumab inhibits the protein sclerostin to increase bone formation and decrease bone resorption.

In the Journals

Female physicians make 'substantially' less than male counterparts

July 22, 2016
Significant salary differences exist between male and female physicians at public medical schools, according to findings published in JAMA Internal Medicine. This gap…

Top 5 online stories posted in the last month

July 22, 2016
Endocrine Today compiled a list of the top five news reports posted from June 21 to July 21. Healio.com/Endocrinology readers were interested in a new name proposed for…
In the Journals

Individuals with mood disorders, low cortisol may have higher risk for obesity, other metabolic disorders

July 22, 2016
Recent findings indicated associations between low cortisol levels, metabolic disorders and cardiovascular risk factors among individuals with mood disorders…

Nearly half of physicians see fewer patients each day due to EHR use

July 22, 2016
Physicians have mixed feelings about electronic health record usage, according to a report published by Physicians Practice. The 2016 Tech Report included an annual…
More News Headlines »
CME

Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Video
Meeting News Coverage

VIDEO: CGM allows assessment of glucose variability

June 13, 2016
More »
Featured
Highlights from ADA

Highlights from ADA

CME Video

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
Current Issues
View the Current Issues
morganatic-roan